BCPC · Balchem Corporation
$161.00
-0.68% last session
End-of-day data · updated 2026-07-25
Market cap
$5B
Enterprise value
$5B
Trailing P/E
33.5
Forward P/E
26.7
Dividend yield
1.0%
Beta
0.81
Avg volume
0M
Employees
1K
2D change
1.12%
5D change
-0.10%
10D change
0.07%
30D change
-3.79%
60D change
0.81%
MTD change
-3.60%
YTD change
6.16%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — BCPC
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-05-04
Latest call per bank · past 12 months
Recent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-05-04 | HC Wainwright & Co. | Maintains | Buy | $5.10 → $5.16 |
| 2026-02-24 | HC Wainwright & Co. | Maintains | Buy | $190 |
| 2025-12-05 | Rothschild & Co | Initiates | Neutral | $0.00 → $162 |
| 2025-10-22 | HC Wainwright & Co. | Maintains | Buy | $189 → $190 |
| 2025-08-04 | HC Wainwright & Co. | Maintains | Buy | $180 → $189 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-23
- RSI (14): RSI is 42 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 1.2% below the 50-day MA ($162.96).
- Price vs 200-day MA: Trading 1.1% below the 200-day MA ($162.81).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-0.55) — short-term momentum is fading.
- 52-week range: Price sits between the 52-week low ($139.44) and high ($183.26).
BCPC Price Chart
Loading chart for BCPC…
Fundamentals
About Balchem Corporation
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
More in Specialty Chemicals
LIN
Linde plc
$237B 20.9% YTD
SHW
Sherwin-Williams Company (The)
$78B -1.5% YTD
ECL
Ecolab Inc.
$76B 2.9% YTD
APD
Air Products and Chemicals, Inc
$66B 23.0% YTD
PPG
PPG Industries, Inc.
$26B 14.6% YTD
SQM
Sociedad Quimica y Minera S.A.
$20B 1.0% YTD
LYB
LyondellBasell Industries NV
$19B 42.5% YTD
ALB
Albemarle Corporation
$14B -18.4% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.